Qing Zhu

15PUBLICATIONS
8CO-AUTHORS
Predictive and prognostic markersCell development, proliferation and deathMolecular targetsCancer geneticsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 15, 2026
Serum SAMD9 as a Potential Prognostic Biomarker for Pancreatic Cancer.

|Jun 20, 2026
SPOP-mediated nuclear ubiquitination degradation of p62/SQSTM1 contributes to HR repair.

|Apr 14, 2026
Agrimol B inhibits pancreatic ductal adenocarcinoma by induction of lethal mitophagy through decreasing mitochondrial transcription termination factor 3.

Yifei Ma, Ying Zheng, Ying Zhou

|Feb 15, 2025
p62/SQSTM1 in cancer: phenomena, mechanisms, and regulation in DNA damage repair.

Xiaojuan Yang, Xunjie Cao, Qing Zhu

|Oct 26, 2024
Establishment and Verification of a Novel Gene Signature Connecting Hypoxia and Lactylation for Predicting Prognosis and Immunotherapy of Pancreatic Ductal Adenocarcinoma Patients by Integrating Multi-Machine Learning and Single-Cell Analysis.

Ying Zheng, Yang Yang, Qunli Xiong

|Mar 05, 2024
tiRNA-Val-CAC-2 interacts with FUBP1 to promote pancreatic cancer metastasis by activating c‑MYC transcription.

Qunli Xiong, Yaguang Zhang, Yongfeng Xu

Pageof 3

Frequent Collaborators

3 joint publications

Qunli Xiong

3 joint publications

Junhong Han

2 joint publications

Yaguang Zhang

2 joint publications

Zhiwei Zhang